(Q62812345)

English

Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

4-Week Multicenter, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Safety and Efficacy Study of PUR 0110 (Thykamine™) Cream Applied Twice Daily in Mild-to-Moderate Atopic Dermatitis (English)

0 references

0 references

0 references

0 references

23 October 2017

0 references

end time

31 December 2019

0 references

number of participants

92

0 references

clinical trial phase

phase II clinical trial

0 references

research subject recruitment status

recruiting

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03540043

0 references

(Q62812345)

Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)